Proteases of Porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: A review article

Current Drug Targets

Volumn 12, Issue 3, 2011, Pages 322-331

  Grenier, Daniel ^a   La, Vu Dang ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Flavonoid; Gingipain; Periodontitis; Polyphenol; Porphyromonas gingivalis; Protease; Protease inhibitor; Virulence factor

Indexed keywords

ALLICIN; BACTERIAL ENZYME; BERBERINE; CATECHIN; COLLAGENASE; DIPEPTIDYL PEPTIDASE IV; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; EUCALYPTUS EXTRACT; GALLOCATECHIN; GARLIC EXTRACT; GINGIPAIN R; GREEN TEA EXTRACT; LYS GINGIPAIN; MALABARICONE C; PHLOROGLUCINOL DERIVATIVE; POLYPHENOL; PROANTHOCYANIDIN; PROCYANIDIN; PROTEINASE; PROTEINASE INHIBITOR; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APPLE; ARTICLE; BACTERIAL VIRULENCE; COPTIS; CRANBERRY; CRANBERRY JUICE; DRUG TARGETING; ELM; ENDOSPERM; ENZYME ACTIVITY; EUCALYPTUS; GARLIC; HOPS; HOST RESISTANCE; HUMAN; INFLAMMATION; NONHUMAN; NUTMEG; PATHOGENICITY; PERIODONTAL DISEASE; PERIODONTITIS; PLANT LEAF; PLANT SEED; PORPHYROMONAS GINGIVALIS; PROTEIN DEGRADATION; PROTEINASE INHIBITION; PROTEOMICS; RICE; TEA;

EID: 79551627448     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945011794815310     Document Type: Article

References (114)

1. Williams RC. Periodontal disease. N Engl J Med 1990; 322(6): 373-82.
2. The American Academy of Periodontology. Epidemiology of periodontal diseases. J Periodontol 1996; 67(9): 935-45.
3. Schenkein HA. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol 2000 2006; 40: 77-93.
4. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998; 9(3): 248-66.
5. Paster BJ, Boches SK, Galvin JL, et al. Bacterial diversity in human subgingival plaque. J Bacteriol 2001; 183(12): 3770-83.
6. Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 1999; 20: 168-238.
7. Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 1998; 62(4): 1244-63.
8. Melvin WL, Assad DA, Miller GA, Gher ME, Simonson L, York AK. Comparison of DNA probe and ELISA microbial analysis methods and their association with adult periodontitis. J Periodontol 1994; 65(6): 576-82.
9. Socransky SS, Haffajee AD, Smith C, Dibart S. Relation of counts of microbial species to clinical status at the sampled site. J Clin Periodontol 1991; 18(10): 766-75.
10. Griffen AL, Becker MR, Lyons SR, Moeschberger ML, Leys EJ. Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol 1998; 36(11): 3239-42.
11. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994; 65(3): 260-7.
12. Curtis MA, Kuramitsu HK, Lantz M, et al. Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis. J Periodontal Res 1999; 34(8): 464-72.
13. Mikolajczyk-Pawlinska J, Kordula T, Pavloff N, et al. Genetic variation of Porphyromonas gingivalis genes encoding gingipains, cysteine proteinases with arginine or lysine specificity. Biol Chem 1998; 379(2): 205-11.
14. Potempa J, Sroka A, Imamura T, Travis J. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci 2003; 4(6): 397-407.
15. Curtis MA, Thickett A, Slaney JM, et al. Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. Infect Immun 1999; 67(8): 3816-23.
16. Rangarajan M, Aduse-Opoku J, Slaney JM, Young KA, Curtis MA. The prpR1 and prR2 arginine-specific protease genes of Porphyromonas gingivalis W50 produce five biochemically distinct enzymes. Mol Microbiol 1997; 23(5): 955-65.
17. Birkedal-Hansen H, Taylor RE, Zambon JJ, Barwa PK, Neiders ME. Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodontal Res 1988; 23(4): 258-64.
18. Houle MA, Grenier D, Plamondon P, Nakayama K. The collagenase activity of Porphyromonas gingivalis is due to Arggingipain. FEMS Microbiol Lett 2003; 221(2): 181-5.
19. Kato T, Takahashi N, Kuramitsu HK. Sequence analysis and characterization of the Porphyromonas gingivalis prtC gene, which expresses a novel collagenase activity. J Bacteriol 1992; 174(12): 3889-95.
20. Lawson DA, Meyer TF. Biochemical characterization of Porphyromonas (Bacteroides) gingivalis collagenase. Infect Immun 1992; 60(4): 1524-9.
21. Grenier D, McBride BC. Isolation of a membrane-associated Bacteroides gingivalis glycylprolyl protease. Infect Immun 1987; 55(12): 3131-6.
22. Abiko Y, Hayakawa M, Murai S, Takiguchi H. Glycylprolyl dipeptidylaminopeptidase from Bacteroides gingivalis. J Dent Res 1985; 64(2): 106-11.
23. Kumagai Y, Yagishita H, Yajima A, Okamoto T, Konishi K. Molecular mechanism for connective tissue destruction by dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis. Infect Immun 2005; 73(5): 2655-64.
24. Nelson D, Potempa J, Kordula T, Travis J. Purification and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis. Evidence for a role in the inactivation of human alpha1-proteinase inhibitor. J Biol Chem 1999; 274(18): 12245-51.
25. Banbula A, Mak P, Bugno M, et al. Prolyl tripeptidyl peptidase from Porphyromonas gingivalis. A novel enzyme with possible pathological implications for the development of periodontitis. J Biol Chem 1999; 274(14): 9246-52.
26. Madden TE, Clark VL, Kuramitsu HK. Revised sequence of the Porphyromonas gingivalis prtT cysteine protease/hemagglutinin gene: homology with streptococcal pyrogenic exotoxin B/streptococcal proteinase. Infect Immun 1995; 63(1): 238-47.
27. Bourgeau G, Lapointe H, Peloquin P, Mayrand D. Cloning, expression, and sequencing of a protease gene (tpr) from Porphyromonas gingivalis W83 in Escherichia coli. Infect Immun 1992; 60(8): 3186-92.
28. Awano S, Ansai T, Mochizuki H, et al. Sequencing, expression and biochemical characterization of the Porphyromonas gingivalis pepO gene encoding a protein homologous to human endothelinconverting enzyme. FEBS Lett 1999; 460(1): 139-44.
29. Banbula A, Yen J, Oleksy A, et al. Porphyromonas gingivalis DPP-7 represents a novel type of dipeptidylpeptidase. J Biol Chem 2001; 276(9): 6299-305.
30. Cutler CW, Kalmar JR, Genco CA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol 1995; 3(2): 45-51.
31. DeCarlo AA, Harber GJ. Hemagglutinin activity and heterogeneity of related Porphyromonas gingivalis proteinases. Oral Microbiol Immunol 1997; 12(1): 47-56.
32. Chen T, Duncan MJ. Gingipain adhesin domains mediate Porphyromonas gingivalis adherence to epithelial cells. Microb Pathog 2004; 36(4): 205-9.
33. Chen T, Nakayama K, Belliveau L, Duncan MJ. Porphyromonas gingivalis gingipains and adhesion to epithelial cells. Infect Immun 2001; 69(5): 3048-56.
34. Gibbons RJ. Bacterial adhesion to oral tissues: a model for infectious diseases. J Dent Res 1989; 68(5): 750-60.
35. Gibbons RJ, Hay DI, Childs WC, 3rd, Davis G. Role of cryptic receptors (cryptitopes) in bacterial adhesion to oral surfaces. Arch Oral Biol 1990; 35 Suppl: 107S-14S.
36. Kadowaki T, Nakayama K, Yoshimura F, Okamoto K, Abe N, Yamamoto K. Arg-gingipain acts as a major processing enzyme for various cell surface proteins in Porphyromonas gingivalis. J Biol Chem 1998; 273(44): 29072-6.
37. Onoe T, Hoover CI, Nakayama K, Ideka T, Nakamura H, Yoshimura F. Identification of Porphyromonas gingivalis prefimbrilin possessing a long leader peptide: possible involvement of trypsin-like protease in fimbrilin maturation. Microb Pathog 1995; 19(5): 351-64.
38. Xie H, Chung WO, Park Y, Lamont RJ. Regulation of the Porphyromonas gingivalis fimA (Fimbrillin) gene. Infect Immun 2000; 68(12): 6574-9.
39. Nakayama K, Yoshimura F, Kadowaki T, Yamamoto K. Involvement of arginine-specific cysteine proteinase (Arggingipain) in fimbriation of Porphyromonas gingivalis. J Bacteriol 1996; 178(10): 2818-24.
40. Weinberg A, Belton CM, Park Y, Lamont RJ. Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1997; 65(1): 313-6.
41. Shah HN, Gharbia SE. Batch culture and physiological properties. In: Shah HN, Mayrand D, Genco RJ, Eds, Biology of the species Porphyromonas gingivalis. Boca Raton, USA: CRC Press 1993: pp. 85-103.
42. Grenier D, Roy S, Chandad F, et al. Effect of inactivation of the Arg- and/or Lys-gingipain gene on selected virulence and physiological properties of Porphyromonas gingivalis. Infect Immun 2003; 71(8): 4742-8.
43. Brochu V, Grenier D, Nakayama K, Mayrand D. Acquisition of iron from human transferrin by Porphyromonas gingivalis: a role for Arg- and Lys-gingipain activities. Oral Microbiol Immunol 2001; 16(2): 79-87.
44. Lewis JP, Dawson JA, Hannis JC, Muddiman D, Macrina FL. Hemoglobinase activity of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83. J Bacteriol 1999; 181(16): 4905-13.
45. Kilian M. Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens. Infect Immun 1981; 34(3): 757-65.
46. Sundqvist G, Carlsson J, Herrmann B, Tarnvik A. Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J Med Microbiol 1985; 19(1): 85-94.
47. Fletcher HM, Schenkein HA, Morgan RM, Bailey KA, Berry CR, Macrina FL. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene. Infect Immun 1995; 63(4): 1521-8.
48. Schenkein HA, Fletcher HM, Bodnar M, Macrina FL. Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complementderived opsonins. J Immunol 1995; 154(10): 5331-7.
49. Nakayama K, Kadowaki T, Okamoto K, Yamamoto K. Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence. J Biol Chem 1995; 270(40): 23619-26.
50. Grenier D. Inactivation of human serum bactericidal activity by a trypsinlike protease isolated from Porphyromonas gingivalis. Infect Immun 1992; 60(5): 1854-7.
51. Grenier D. Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola. Microbiology 1996; 142(Pt 4): 955-61.
52. Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J, Hugli TE. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem 1992; 267(26): 18902-7.
53. Engel D, Grenier D, Hobbs M, Morgan E, Hugli TE, Weigle WO. Inflammatory potential of IgG Fc fragments generated by Porphyromonas gingivalis protease. FASEB J 1994; 8: 223.
54. Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, Potempa J. Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun 1999; 261(3): 598-602.
55. Calkins CC, Platt K, Potempa J, Travis J. Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem 1998; 273(12): 6611-4.
56. Fletcher J, Reddi K, Poole S, et al. Interactions between periodontopathogenic bacteria and cytokines. J Periodontal Res 1997; 32(1 Pt 2): 200-5.
57. Mikolajczyk-Pawlinska J, Travis J, Potempa J. Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett 1998; 440(3): 282-6.
58. Oleksy A, Banbula A, Bugno M, Travis J, Potempa J. Proteolysis of interleukin-6 receptor (IL-6R) by Porphyromonas gingivalis cysteine proteinases (gingipains) inhibits interleukin-6-mediated cell activation. Microb Pathog 2002; 32(4): 173-81.
59. Duncan L, Yoshioka M, Chandad F, Grenier D. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 2004; 36(6): 319-25.
60. Fitzpatrick RE, Aprico A, Wijeyewickrema LC, et al. High molecular weight gingipains from Porphyromonas gingivalis induce cytokine responses from human macrophage-like cells via a non-proteolytic mechanism. J Innate Immun 2009; 1: 109-17.
61. Lourbakos A, Potempa J, Travis J, et al. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 2001; 69(8): 5121-30.
62. O'Brien-Simpson NM, Pathirana RD, Walker GD, Reynolds EC. Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun 2009; 77(3): 1246-61.
63. Uehara A, Imamura T, Potempa J, Travis J, Takada H. Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through proteaseactivated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol 2008; 10(5): 1181-9.
64. Imamura T, Pike RN, Potempa J, Travis J. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest 1994; 94(1): 361-7.
65. Imamura T, Potempa J, Tanase S, Travis J. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem 1997; 272(25): 16062-7.
66. Lantz MS, Allen RD, Duck LW, Switalski LM, Hook M. Porphyromonas gingivalis surface components bind and degrade connective tissue proteins. J Periodontal Res 1991; 26(3 Pt 2): 283-5.
67. Potempa J, Pike RN, Travis J. Host and Porphyromonas gingivalis proteinases in periodontitis: A biochemical model of infection and tissue destruction. Perspect Drug Discovery Design 1995; 2: 445-58.
68. DeCarlo AA, Grenett HE, Harber GJ, et al. Induction of matrix metalloproteinases and a collagen-degrading phenotype in fibroblasts and epithelial cells by secreted Porphyromonas gingivalis proteinase. J Periodontal Res 1998; 33(7): 408-20.
69. DeCarlo AA, Jr., Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B, Birkedal-Hansen H. Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res 1997; 76(6): 1260-70.
70. Uitto VJ, Larjava H, Heino J, Sorsa T. A protease of Bacteroides gingivalis degrades cell surface and matrix glycoproteins of cultured gingival fibroblasts and induces secretion of collagenase and plasminogen activator. Infect Immun 1989; 57(1): 213-8.
71. Sorsa T, Ingman T, Suomalainen K, et al. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun 1992; 60(11): 4491-5.
72. Grenier D, Mayrand D. Inactivation of tissue inhibitor of metalloproteinases-1 (TIMP-1) by Porphyromonas gingivalis. FEMS Microbiol Lett 2001; 203(2): 161-4.
73. Darenfed H, Grenier D, Mayrand D. Acquisition of plasmin activity by Fusobacterium nucleatum subsp. nucleatum and potential contribution to tissue destruction during periodontitis. Infect Immun 1999; 67(12): 6439-44.
74. Katz J, Sambandam V, Wu JH, Michalek SM, Balkovetz DF. Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect Immun 2000; 68(3): 1441-9.
75. Andrian E, Grenier D, Rouabhia M. Porphyromonas gingivalis gingipains mediate the shedding of syndecan-1 from the surface of gingival epithelial cells. Oral Microbiol Immunol 2006; 21(2): 123-8.
76. Bernfield M, Gotte M, Park PW, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-77.
77. Andrian E, Grenier D, Rouabhia M. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun 2004; 72(8): 4689-98.
78. Baldwin DA, Jenny ER, Aisen P. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J Biol Chem 1984; 259(21): 13391-4.
79. Goulet V, Britigan B, Nakayama K, Grenier D. Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals. Infect Immun 2004; 72(8): 4351-6.
80. Sorsa T, Saari H, Konttinen YT, Suomalainen K, Lindy S, Uitto VJ. Non-proteolytic activation of latent human neutrophil collagenase and its role in matrix destruction in periodontal diseases. Int J Tissue React 1989; 11(4): 153-9.
81. Bartold PM, Wiebkin OW, Thonard JC. The effect of oxygenderived free radicals on gingival proteoglycans and hyaluronic acid. J Periodontal Res 1984; 19(4): 390-400.
82. Miwa T, Song WC. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int Immunopharmacol 2001; 1(3): 445-59.
83. Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP. CD46: expanding beyond complement regulation. Trends Immunol 2004; 25(9): 496-503.
84. Mahtout H, Chandad F, Rojo JM, Grenier D. Porphyromonas gingivalis mediates the shedding and proteolysis of complement regulatory protein CD46 expressed by oral epithelial cells. Oral Microbiol Immunol 2009; 24(5): 396-400.
85. Lovkvist L, Sjolinder H, Wehelie R, et al. CD46 Contributes to the severity of group A streptococcal infection. Infect Immun 2008; 76(9): 3951-8.
86. Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J. Role of gingipains R in the pathogenesis of Porphyromonas gingivalismediated periodontal disease. Clin Infect Dis 1999; 28(3): 456-65.
87. Watanabe H, Marsh PD, Ivanyi L. Detection of immunodominant antigens of periodontopathic bacteria in human periodontal disease. Oral Microbiol Immunol 1989; 4(3): 159-64.
88. Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun 1998; 66(9): 4108-14.
89. O'Brien-Simpson NM, Paolini RA, Reynolds EC. RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model. Infect Immun 2000; 68(7): 4055-63.
90. Kuboniwa M, Amano A, Shizukuishi S, Nakagawa I, Hamada S. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection. Infect Immun 2001; 69(5): 2972-9.
91. Yonezawa H, Ishihara K, Okuda K. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Infect Immun 2001; 69(5): 2858-64.
92. Pathirana RD, O'Brien-Simpson NM, Brammar GC, Slakeski N, Reynolds EC. Kgp and RgpB, but not RgpA, are important for Porphyromonas gingivalis virulence in the murine periodontitis model. Infect Immun 2007; 75(3): 1436-42.
93. Curtis MA, Aduse Opoku J, Rangarajan M, et al. Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor. Infect Immun 2002; 70(12): 6968-75.
94. Bagchi D, Sen CK, Ray SD, et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003; 523-524: 87-97.
95. Inaba H, Tagashira M, Kanda T, Ohno T, Kawai S, Amano A. Apple- and hop-polyphenols protect periodontal ligament cells stimulated with enamel matrix derivative from Porphyromonas gingivalis. J Periodontol 2005; 76(12): 2223-9.
96. Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 2009; 126(1): 5-17.
97. Hu JP, Takahashi N, Yamada T. Coptidis rhizoma inhibits growth and proteases of oral bacteria. Oral Dis 2000; 6(5): 297-302.
98. Bodet C, Grenier D, Chandad F, Ofek I, Steinberg D, Weiss EI. Potential oral health benefits of cranberry. Crit Rev Food Sci Nutr 2008; 48: 1-9.
99. Bodet C, Piche M, Chandad F, Grenier D. Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecularweight fraction isolated from cranberry. J Antimicrob Chemother 2006; 57(4): 685-90.
100. Yamanaka A, Kouchi T, Kasai K, Kato T, Ishihara K, Okuda K. Inhibitory effect of cranberry polyphenol on biofilm formation and cysteine proteases of Porphyromonas gingivalis. J Periodontal Res 2007; 42(6): 589-92.
101. La VD, Howell AB, Grenier D. Anti-Porphyromonas gingivalis and Anti-inflammatory Activities of A-Type Cranberry Proanthocyanidins. Antimicrob Agents Chemother 2010; 54(5): 1778-84.
102. La VD, Howell AB, Grenier D. Cranberry proanthocyanidins inhibit MMP production and activity. J Dent Res 2009; 88(7): 627-32.
103. Song SE, Choi BK, Kim SN, et al. Inhibitory effect of procyanidin oligomer from elm cortex on the matrix metalloproteinases and proteases of periodontopathogens. J Periodontal Res 2003; 38(3): 282-9.
104. Nagata H, Inagaki Y, Yamamoto Y, et al. Inhibitory effects of macrocarpals on the biological activity of Porphyromonas gingivalis and other periodontopathic bacteria. Oral Microbiol Immunol 2006; 21(3): 159-63.
105. Block E. The chemistry of garlic and onions. Sci Am 1985; 252(3): 114-9.
106. Bakri IM, Douglas CW. Inhibitory effect of garlic extract on oral bacteria. Arch Oral Biol 2005; 50(7): 645-51.
107. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007; 81(7): 519-33.
108. Okamoto M, Sugimoto A, Leung KP, Nakayama K, Kamaguchi A, Maeda N. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis. Oral Microbiol Immunol 2004; 19(2): 118-20.
109. Sakanaka S, Okada Y. Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-diseasecausing anaerobic bacterium Porphyromonas gingivalis. J Agric Food Chem 2004; 52(6): 1688-92.
110. Makimura M, Hirasawa M, Kobayashi K, et al. Inhibitory effect of tea catechins on collagenase activity. J Periodontol 1993; 64(7): 630-6.
111. Geller SE, Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Womens Health (Larchmt) 2005; 14(7): 634-49.
112. Shinada K, Tagashira M, Watanabe H, et al. Hop bract polyphenols reduced three-day dental plaque regrowth. J Dent Res 2007; 86(9): 848-51.
113. Shinohara C, Mori S, Ando T, Tsuji T. Arg-gingipain inhibition and anti-bacterial activity selective for Porphyromonas gingivalis by malabaricone C. Biosci Biotechnol Biochem 1999; 63(8): 1475-7.
114. Taiyoji M, Shitomi Y, Taniguchi M, Saitoh E, Ohtsubo S. Identification of proteinaceous inhibitors of a cysteine proteinase (an Arg-specific gingipain) from Porphyromonas gingivalis in rice grain, using targeted-proteomics approaches. J Proteome Res 2009; 8(11): 5165-74.